This article deals with concerns about Cabotegravir. It was approved as an injection given every month or 2 months as PrEP. According to the piece, the efficacy of the medicine is high, but not 100%. During the study there was a little over 1% infection. They aren't clear as to what happened yet. The researchers still fear the development of drug resistance with this med. Not a nightmare, but I'd think this would require more study, before moving forward. Nothing is foolproof.
Cya...
No comments:
Post a Comment